All
Therapeutic Development Using Molecular and Nucleic Acid Approaches Ag...
Development of Molecular Targeted and Nucleic Acid Therapeutics for C11orf97
Hydrogen Boride HB: (1) Fuel cell electrode material using low platinu...
-
Phase3 ready Drug repositioning for myotonic dystrophy type 1
Erythromycin binds to CUG-expanded RNA to suppress RNA toxicity and splicing misregulation in DM1.
Exosome Drug for Anti-aging
Life-extending effects confirmed in mice by using the sensor molecule CtBP2, which has broad metabol…
Crispr Therapy for Dentatorubral-Pallidoluysian Atrophy (DRPLA)
Upstream Stop Codon Insertion to Suppress CAG Repeat–Driven Disease Progression
A Plate Culture System for Maintaining a Homeostatic Gas Environment D...
An electricity-free pump powered by shaking motion automatically supplies gas, while a specialized p…
Novel Therapeutic Agent for Severe Cutaneous Adverse Reactions (SJS/TE...
Suppression of epidermal cell death through control of necroptosis by chenodeoxycholic acid
Welding Distortion Simulation Technology
This page is currently available only in Japanese.
Real-time film thickness measurement system
Spectral zoom function and ultra-high-speed data acquisition and analysis with a drastically reduced…
Spectrometer for Real-time Component Analysis
This page is currently available only in Japanese.